Suppr超能文献

当今的肠促胰岛素概念。

The incretin concept today.

作者信息

Creutzfeldt W

出版信息

Diabetologia. 1979 Feb;16(2):75-85. doi: 10.1007/BF01225454.

Abstract
  1. The insulinogenic factor of the gastrointestinal mucosa named "incretin" is only one part of the complex enteroinsular axis. --2. Of the chemically defined gastrointestinal hormones GIP is the strongest incretin candidate. --3. Because of the dual function of GIP as gastrone and insulinotropic substance several safeguards against GIP-mediated insulin hypoglycaemia exist. --4. No pathological condition has yet been found which is causally related to hyper- or hyposecretion of GIP. However, an exaggerated GIP response (usually secondary to the disease) may participate in the pathogenesis of hyperinsulinaemia of patients with obesity and duodenal ulcer. --5. The injection of GIP antibodies only partially abolishes the incretin effect. Therefore, GIP, although important, is not the only incretin.
摘要
  1. 胃肠道黏膜中被称为“肠促胰岛素”的胰岛素生成因子只是复杂的肠胰岛轴的一部分。

  2. 在化学性质明确的胃肠道激素中,胃抑肽是最强的肠促胰岛素候选物。

  3. 由于胃抑肽具有胃泌素和促胰岛素物质的双重功能,因此存在多种防止胃抑肽介导的胰岛素低血糖的保护机制。

  4. 尚未发现与胃抑肽分泌过多或过少存在因果关系的病理状况。然而,胃抑肽反应过度(通常继发于疾病)可能参与肥胖症和十二指肠溃疡患者高胰岛素血症的发病机制。

  5. 注射胃抑肽抗体只能部分消除肠促胰岛素效应。因此,胃抑肽虽然很重要,但不是唯一的肠促胰岛素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验